Literature DB >> 18700932

Ophthalmic manifestations of demyelination secondary to etanercept.

Helen H-J Do, Armin Mohamed, Alexander Klistorner, John Grigg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18700932     DOI： 10.1111/j.1442-9071.2008.001741.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN： 1442-6404            Impact factor:   4.207


× No keyword cloud information.
  3 in total

Review 1.  A case of leukoencephalopathy associated with adalimumab-treated rheumatoid arthritis and a review of literature.

Authors:  Yang-Seon Ryu; Sung-Hwan Park; Ji-Min Kim; Eun-Ji Kim; Jennifer Lee; Seung-Ki Kwok; Ji-Hyeon Ju; Ho-Youn Kim
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

Review 2.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

Review 3.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.